Morphology, atypical chronic lymphocytic leukaemia and prognostic features affecting choice of therapy.
Catovsky
D
D
Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital, London, UK. d.catovsky@icr.ac.uk
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D016130:Immunophenotyping; D015448:Leukemia, B-Cell / Q000175:diagnosis; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000145:classification / Q000188:drug therapy / Q000473:pathology*; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis; D007958:Leukocyte Count; D016131:Lymphocyte Subsets / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000648:ultrastructure
D000970:Antineoplastic Agents